Company Filing History:
1 out of 378 
1 out of 12,160 
Years Active: 2022
Title: The Innovations of Stephan Menz
Introduction
Stephan Menz is a notable inventor based in Berlin, Germany. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative research and development of compounds that target various diseases.
Latest Patents
Menz holds a patent for "Substituted dihydroimidazopyridinediones as MKNK1 and MKNK2 inhibitors." This invention relates to substituted dihydroimidazopyridinedione compounds, which are described and defined in detail. The patent outlines methods for preparing these compounds, intermediate compounds useful for their preparation, and pharmaceutical compositions that include these compounds. The compounds are intended for the treatment or prophylaxis of diseases, particularly hyperproliferative disorders, angiogenesis disorders, inflammatory diseases, and conditions associated with inflammatory pain.
Career Highlights
Throughout his career, Stephan Menz has worked with prominent companies in the pharmaceutical industry, including Bayer Pharma and Bayer AG. His work has contributed to advancements in drug development and therapeutic solutions.
Collaborations
Menz has collaborated with esteemed colleagues such as Ulrich Klar and Rolf Bohlmann, enhancing the impact of his research through teamwork and shared expertise.
Conclusion
Stephan Menz's innovative work in the pharmaceutical field, particularly his patented compounds, showcases his commitment to advancing medical science. His collaborations and career achievements further highlight his significant contributions to the industry.